Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000236

EVP, Chief Development Officer sold 362 shares at $84.30 ($30,517)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kordasiewicz Holly B. EVP, Chief Development Officer 2026-07-07 Sale 10b5-1 −362 $84.30 $30,517 22,096 D: show line 1 in the form
Open-market sales · 362 sh · avg $84.30 · $30,517
Loading xslF345X06/edgardoc.xml…